2001, Number 3
Next >>
Salud Mental 2001; 24 (3)
La psicofarmacogenética. Esperanzas y riesgos
Nicolini H
Language: Spanish
References: 5
Page: 1-2
PDF size: 46.50 Kb.
Text Extraction
No abstract
REFERENCES
ARRANZ M, COLLIER D, SODHI M, BALL D, ROBERTS G, PRICE J, SHAM P, KERWIN R: Association between clozapine response and allelic variation in the 5HT2A receptor gene. Lancet, 346:281-282, 1995.
ARRANZ M, MUNRO J, BIRKETT J, BOLONNA A, MANCAMA D, SODHI M, LESCH KP, MEYER J, SHAM P, COLLIER D, MURRAY M, KERWIN R: Pharmacogenetic prediction of clozapine response. Lancet, 355:1615- 1616, 2000.
BASILE V, MASSELLIS M, BADRI F, PATERSON A, MELTZER H, LIEBERMAN J, POTKIN S, MACCIARDI F, KENNEDY JL: Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia. Neuropsychopharmacology, 21:17-27, 1999.
ELLINGROD V, SCHULTZ S, ARNDT S: Association between cytochrome P450D6 genotype, Antypsychotic Exposure and Abnormal Involuntary Movement Scale (AIMS) score. Psychiatric Genetics, 10(1):9-11, 2000.
ROSES A: Pharmacogenetics and the practice of medicine. Nature, 405:857-865, 2000.
Full text